Alaunos Therapeutics, Inc. (TCRT)
CIK 1107421 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Alaunos Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Oct 23, 2026 | 8-K | 0001193125-26-430507 |
| Oct 21, 2026 | 8-K | 0001193125-26-427890 |
| Oct 15, 2026 | 3 | 0001683168-26-007900 |
| Oct 15, 2026 | SCHEDULE 13D/A | 0001193805-26-001370 |
| Oct 15, 2026 | SCHEDULE 13D | 0001683168-26-007898 |
| Oct 13, 2026 | 8-K | 0001193125-26-419829 |
| Oct 9, 2026 | 8-K | 0001193125-26-419154 |
| Oct 8, 2026 | 4 | 0001193125-26-417970 |
| Oct 8, 2026 | 4 | 0001193125-26-417971 |
| Oct 8, 2026 | 4 | 0001193125-26-417974 |
| Oct 8, 2026 | 4 | 0001193125-26-417969 |
| Sep 22, 2026 | 8-K | 0001193125-26-397996 |
| Sep 21, 2026 | 424B3 | 0001193125-26-396777 |
| Sep 17, 2026 | 8-K | 0001193125-26-393462 |
| Aug 14, 2026 | 10-Q | 0001193125-26-352421 |
| Aug 11, 2026 | 4 | 0001193125-26-344682 |
| Jul 27, 2026 | 4 | 0001193125-26-318103 |
| Jul 27, 2026 | 4 | 0001193125-26-318105 |
| Jul 27, 2026 | 4 | 0001193125-26-318100 |
| Jul 27, 2026 | 4 | 0001193125-26-318114 |
| Jul 6, 2026 | S-8 | 0001193125-26-295169 |
| Jul 2, 2026 | 4 | 0001193125-26-295004 |
| Jun 29, 2026 | 8-K | 0001193125-26-286914 |
| Jun 17, 2026 | 4 | 0001193125-26-274305 |
| May 27, 2026 | 4 | 0001193125-26-241999 |